Your search returned 2 results.

Results
	1.	A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis. [electronic resource] by Jani, Rajendrakumar H Gupta, Rajiv Bhatia, Girish Rathi, Gaurav Ashok Kumar, Patnala Sharma, Reena Kumar, Uma Gauri, Liyakat A Jadhav, Praveen Bartakke, Girishchandra Haridas, Vikram Jain, Dinesh Mendiratta, Sanjeev K Producer: 20170523 In: International journal of rheumatic diseases vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis. [electronic resource] by Pitale, Shailesh Thomas, Mathew Rathi, Gaurav Deshmukh, Vaishali Kumar, Prasanna Reddy, Sanjay Shetty, Naresh Kakar, Atul Babhulkar, Sushrut Mody, Bharat Chacko, Jacob Acharya, Sudeep Joglekar, Sadhna Halbe, Vipul Kravitz, Barbara G Waterhouse, Brian Nino, Antonio J Fitzpatrick, Lorraine A Producer: 20150116 In: Indian journal of endocrinology and metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search